J. Dyr

发表

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

J. Čermák, K. Pecankova, P. Májek, 2015, BioMed research international.

The Effect of Reagents Mimicking Oxidative Stress on Fibrinogen Function

K. Pimková, J. Dyr, T. Riedel, 2013, TheScientificWorldJournal.

Effects of malondialdehyde content in low density lipoproteins on platelet adhesion

J. Čermák, J. Dyr, J. Suttnar, 2006, Platelets.

Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space

J. Weisel, J. Dyr, T. Riedel, 2021, Thrombosis and Haemostasis.

Controlled preparation of thin fibrin films immobilized at solid surfaces.

M. Houška, E. Brynda, J. Dyr, 2009, Journal of biomedical materials research. Part A.

Simplified platelet sample preparation for SDS‐PAGE‐based proteomic studies

P. Májek, J. Dyr, T. Riedel, 2012, Proteomics. Clinical applications.

Two novel mutations in the fibrinogen γ nodule.

P. Salaj, J. Dyr, T. Riedel, 2014, Thrombosis research.

A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function

P. Májek, J. Dyr, T. Riedel, 2013, Thrombosis and Haemostasis.

Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo

J. Kvasnička, P. Salaj, J. Dyr, 2010, Journal of Thrombosis and Thrombolysis.

The adhesion of blood platelets on fibrinogen surface: Comparison of two biochemical microplate assays

J. Dyr, J. Suttnar, M. Vanícková, 2006, Platelets.

Fibrin Clot Formation under Oxidative Stress Conditions

J. Dyr, Jana Štikarová, J. Suttnar, 2021, Antioxidants.

A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis

J. Homola, N. Lynn, M. Hubálek, 2019, Scientific Reports.

Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes

J. Čermák, P. Májek, J. Dyr, 2017, Free radical biology & medicine.

Hemocompatible albumin-heparin coatings prepared by the layer-by-layer technique. The effect of layer ordering on thrombin inhibition and platelet adhesion.

M. Houška, E. Brynda, J. Dyr, 2008, Journal of biomedical materials research. Part A.

Surface interactions of oxidized cellulose with fibrin(ogen) and blood platelets

J. Homola, J. Dostálek, J. Dyr, 2003 .

Proteomic analysis of plasma samples from acute coronary syndrome patients - the pilot study.

J. Veselka, P. Májek, J. Dyr, 2012, International journal of cardiology.

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload

J. Čermák, J. Dyr, Jana Štikarová, 2014, Oxidative medicine and cellular longevity.

Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin

P. Májek, J. Dyr, Jana Štikarová, 2010, Proteome Science.

Antioxidants change platelet responses to various stimulating events.

J. Weisel, P. Májek, J. Dyr, 2009, Free radical biology & medicine.

The action of prothrombin activated by Ecarin on fibrinogen.

J. Dyr, B. Blombäck, F. Kornalík, 1983, Thrombosis research.

Abnormal Fibrinogen Zlín (γThr21Ile) with Missense Mutation Causing Hypofibrinogenemia

P. Májek, J. Dyr, T. Riedel, 2014, Acta Haematologica.

Fibrinogen Šumperk II: Dysfibrinogenemia in an individual with two coding mutations

J. Dyr, R. Kotlín, J. Suttnar, 2012, American journal of hematology.

Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň

P. Salaj, J. Dyr, T. Riedel, 2009, Thrombosis and Haemostasis.

Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders

M. Kuchař, H. Petroková, P. Malý, 2019, Pharmaceutics.

Molecular arrangement of adsorbed fibrinogen molecules characterized by specific monoclonal antibodies and a surface plasmon resonance sensor

Radan Slavik, Jiří Homola, Eduard Brynda, 1998 .

A and B release in the process of surface fibrin formation Short title for the running head : fibrinopeptide release from surface fibrin

M. Houška, E. Brynda, J. Dyr, 2010 .

Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings.

M. Houška, L. Bačáková, E. Brynda, 2009, Journal of biomedical materials research. Part A.

Platelet Adhesion to Fibrinogen, Fibrin Monomer, and Fibrin Protofibrils in Flowing Blood - The Effect of Fibrinogen Immobilization and Fibrin Formation

J. Dyr, K. Holada, J. Suttnar, 1997, Thrombosis and Haemostasis.

Optical sensing of the initial stages in the growth and development of fibrin clot

Jiří Homola, Petr Tobiska, J. Homola, 2001 .

Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications

J. Dyr, Jana Štikarová, R. Kotlín, 2022, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease

J. Dyr, M. Šrámek, J. Suttnar, 2020, Metabolites.

N-Glycosylation of apolipoprotein A1 in cardiovascular diseases.

K. Pecankova, P. Májek, J. Dyr, 2015, Translational research : the journal of laboratory and clinical medicine.

Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aα 16 Arg→Cys and Aα 16 Arg→His dysfibrinogenemia

J. Blatny, P. Salaj, J. Šantrůček, 2007 .

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2

J. Čermák, K. Pecankova, P. Májek, 2014, Disease markers.

Protein Carbonylation in Patients with Myelodysplastic Syndromes

J. Čermák, P. Májek, J. Dyr, 2015 .

Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome

J. Čermák, J. Dyr, Jana Štikarová, 2013, Journal of Hematology & Oncology.

Comparative study of human monocyte and platelet adhesion to hydrogels in vitro – effect of polymer structure

K. Smetana, J. Vacík, J. Lukáš, 1997, Journal of materials science. Materials in medicine.

Versatile modular microelectrophoresis system and the simultaneous preparation of large numbers of polyacrylamide gels.

J. Dyr, K. Holada, J. Suttnar, 1991, Journal of chromatography.

Improved Coomassie Blue Dye-Based Fast Staining Protocol for Proteins Separated by SDS-PAGE

K. Pecankova, P. Májek, J. Dyr, 2013, PloS one.

The effect of the biological variability of samples on Coomassie blue dye based fast staining for SDS‐PAGE in nonfixed gels

K. Pecankova, P. Májek, J. Dyr, 2014, Electrophoresis.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

J. Čermák, K. Pecankova, P. Májek, 2017, Cancer biomarkers : section A of Disease markers.

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups

J. Čermák, K. Pecankova, P. Májek, 2015, International journal of laboratory hematology.

Surface plasmon resonance biosensor for the detection of VEGFR-1—a protein marker of myelodysplastic syndromes

J. Homola, J. Čermák, J. Dyr, 2011, Analytical and Bioanalytical Chemistry.

Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor.

J. Homola, Hana Vaisocherová, Hana Šípová, 2015, Biosensors & bioelectronics.

The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.

J. Homola, P. Salaj, J. Dyr, 2007, Journal of biomedical materials research. Part A.

Characterization of platelet antigen for CD45RA monoclonal antibodies.

J. Dyr, K. Holada, J. Šimák, 1995, Immunobiology.

Fibrinogen Aarhus--a new case of dysfibrinogenemia.

B. Kudryk, J. Dyr, B. Blombäck, 1986, Thrombosis research.

Isolation of the prothrombin-converting enzyme from fibrinogenolytic enzymes of Echis carinatus venom by chromatographic and electrophoretic methods.

J. Dyr, Z. Vodráẑka, H. Fořtová, 1983, Journal of chromatography.

Fractionation of Echis carinatus venom by affinity chromatography on immobilized lectins.

J. Dyr, Z. Vodráẑka, H. Fořtová, 1983, Journal of chromatography.

On the increased retention volume of human haemoglobin in high-performance gel filtration.

J. Dyr, J. Suttnar, 1987, Journal of chromatography.

The fibrinogenolytic and procoagulant activity of southern copperhead venom enzymes.

J. Dyr, B. Blombäck, F. Kornalík, 1983, Thrombosis research.

Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy.

P. Salaj, J. Dyr, R. Kotlín, 2011, Thrombosis research.

Simultaneous isolation of protein C activator, fibrin clot promoting enzyme (fibrozyme) and phospholipase A2 from the venom of the southern copperhead snake.

J. Dyr, J. Suttnar, H. Fořtová, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Isolation of a fibrinogen-converting enzyme ficozyme from the venom of Bothrops asper by one-step affinity chromatography on blue sepharose.

J. Dyr, J. Suttnar, H. Fořtová, 1990, Journal of chromatography.

Fibrinogenolytic effect of ecarin a prothrombin converting enzyme.

J. Dyr, Z. Vodráẑka, H. Fořtová, 1979, Thrombosis research.

Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography.

J. Dyr, J. Suttnar, L. Másová, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Acquired Dysfibrinogenemia Secondary to Multiple Myeloma

P. Salaj, P. Májek, J. Dyr, 2008, Acta Haematologica.

Hemostyptic effect of oxidized cellulose on blood platelets.

J. Homola, J. Dostálek, P. Salaj, 2003, Sbornik lekarsky.

Impact of posttranslational modifications on atomistic structure of fibrinogen

Ž. Sovová, P. Májek, J. Dyr, 2020, PloS one.

Chemical binding of folic acid and methotrexate to bovine fibrinogen.

J. Dyr, K. Slavik, Z. Vodráẑka, 1983, Thrombosis research.

Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.

J. Dyr, B. Blombäck, B. Hessel, 1989, Biochimica et biophysica acta.

Albumin and heparin multilayer coatings for blood-contacting medical devices.

M. Houška, E. Brynda, J. Dyr, 2000, Journal of biomedical materials research.

Ecarin-mediated release of fibrinopeptides in human plasma.

J. Dyr, B. Blombäck, F. Kornalík, 1983, Thrombosis research.

Solid-phase extraction in malondialdehyde analysis.

J. Čermák, J. Dyr, J. Suttnar, 1997, Analytical biochemistry.

Complete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfaces.

M. Houška, C. Rodriguez-Emmenegger, E. Brynda, 2013, Langmuir : the ACS journal of surfaces and colloids.

Procedure for refolding and purification of recombinant proteins from Escherichia coli inclusion bodies using a strong anion exchanger.

J. Dyr, V. Vonka, J. Novák, 1994, Journal of chromatography. B, Biomedical applications.

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia

J. Čermák, P. Májek, J. Dyr, 2011, Proteome Science.

Three cases of abnormal fibrinogens: Šumperk (Bβ His67Leu), Uniãov (Bβ Gly414Ser), and Brno (γArg275His)

D. Pospíšilová, P. Smejkal, P. Salaj, 2008, Thrombosis and Haemostasis.

A novel fibrinogen variant – Praha I: hypofibrinogenemia associated with γ Gly351Ser substitution

P. Salaj, J. Šantrůček, J. Dyr, 2007 .

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1

K. Pecankova, P. Májek, J. Dyr, 2011, Journal of Translational Medicine.

Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain

Ž. Sovová, J. Dyr, J. Suttnar, 2021, Metabolites.

No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia

H. Klamová, J. Mužík, J. Dyr, 2014, Hematological oncology.

Alteration of Serum Malondialdehyde Level As Biomarker of Oxidative Stress during Acute Myeloid Leukemia Treatment

J. Dyr, Jana Štikarová, R. Kotlín, 2019, Blood.

Determination of plasma fibrinogen concentration by the modified clot-weight method.

J. Dyr, Z. Vodráẑka, 1974, Thrombosis research.

Fast protein liquid chromatography of Echis carinatus venom.

J. Dyr, Z. Vodráẑka, H. Fořtová, 1983, Journal of chromatography.

Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).

J. Dyr, J. Suttnar, B. Blombäck, 1989, Toxicon : official journal of the International Society on Toxinology.

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

J. Čermák, K. Pecankova, P. Májek, 2015, BioMed research international.

Hsp70 Trap Assay for Detection of Misfolded Subproteome Related to Myelodysplastic Syndromes.

J. Homola, J. Čermák, J. Dyr, 2019, Analytical chemistry.

A novel fibrinogen variant – Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution

P. Salaj, J. Dyr, T. Riedel, 2008, European journal of haematology.

Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-beta-D-thiogalactopyranoside.

I. Hirsch, J. Dyr, V. Vonka, 1994, Journal of chromatography. B, Biomedical applications.

Fibrinopeptides A and B release in the process of surface fibrin formation.

M. Houška, E. Brynda, J. Dyr, 2011, Blood.

Targeted Metabolomic Profiling in Acute Myeloid Leukemia with IDH2R140 and IDH2R172 Mutations

J. Dyr, Jana Štikarová, R. Kotlín, 2018, Blood.

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome

J. Čermák, P. Májek, J. Dyr, 2012, Proteome Science.

The formation of a somatic mutation in the HLA-B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia.

J. Březinová, J. Dyr, M. Belickova, 2019, HLA.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia.

H. Votavova, J. Čermák, J. Dyr, 2018, Cancer biomarkers : section A of Disease markers.

Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome.

Ž. Sovová, J. Čermák, K. Pecankova, 2022, Cancer biomarkers : section A of Disease markers.

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

J. Čermák, K. Pecankova, P. Májek, 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome

J. Čermák, K. Pecankova, P. Májek, 2013, Proteome Science.

Determination of the Putative Binding Sites for Thrombin Receptor Activating Peptide through a Hydropathic Complementary Approach

J. Dyr, J. Suttnar, L. Dolečková, 2000, Thrombosis and Haemostasis.

Comparison of several mouse and rat monoclonal antibodies against human fibrinogen.

J. Dyr, H. Cajthamlová, F. Marecek, 1996, Hybridoma.

Distortion of the electrophoretic titration curves of some proteins

J. Dyr, J. Suttnar, 1989, Electrophoresis.

Research Article Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

J. Čermák, K. Pecankova, P. Májek, 2022 .